advertisement

---

Tang X 16

Showing records 1 to 16 | Display all abstracts from Tang X

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Sun X
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Ye D; Xu Y
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Liu Q; Tang X
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Shi Y; Fan M
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Yao K; Li Y
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Lu P; Bai X
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Yang J
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Feng Y
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Zhang M; Yuan H
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Hu C
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Zheng Y
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Cui K; Tang X
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Li W
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Liao J
Journal of Pineal Research 2022; 73: e12828

---

104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Peng H
BMC Ophthalmology 2022; 22: 332

---

105078 Anti-PANoptosis is involved in neuroprotective effects of melatonin in acute ocular hypertension model
Huang W; Xu F; Liang X; Huang J
Journal of Pineal Research 2022; 73: e12828

---